Monday, May 05, 2014 9:48:31 PM
.................that he is in agreement with Martin. Had loyal shareholders not risked THEIR money, SCRC would not have been able to switch gears and concentrate on the compounding of drugs. When reading the press release today I had almost a million reasons to smile. In my opinion when the Rapimeds is sent to Hong Kong I will have another 200,000 reasons to smile.
As noted in my prior posts in articles I pasted and copied from the Boston Globe this compounding is a homerun and a niche
FEATURED ZenaTech, Inc. (NASDAQ: ZENA) First US Trial of IQ Nano Drone for Inventory Management • Oct 15, 2024 8:21 AM
Kona Gold Beverages, Inc. Announces Strategic Progress and Corporate Evolution • KGKG • Oct 15, 2024 9:00 AM
One World Products Secures First Order for Hemp-Based Reusable Containers, Pioneers Renewable Materials for the Automotive Industry • OWPC • Oct 15, 2024 8:35 AM
CBD Life Sciences, Inc. Announces Strategic MOU with U.S. Armed Forces for Groundbreaking Mushroom Supplement • CBDL • Oct 15, 2024 8:00 AM
HealthLynked Files Non-Provisional Patent for AI-Powered Healthcare Assistant, ARi • HLYK • Oct 15, 2024 8:00 AM
ZenaTech, Inc. (NASDAQ: ZENA) Launchs IQ Nano Drone for Commercial Indoor Use • HALO • Oct 10, 2024 8:09 AM